Rocket Lab (NASDAQ:RKLB) Shares Up 8.4% – Should You Buy?

Rocket Lab Corporation (NASDAQ:RKLBGet Free Report)’s stock price rose 8.4% on Monday . The stock traded as high as $70.60 and last traded at $70.43. Approximately 16,462,825 shares traded hands during trading, a decline of 32% from the average session volume of 24,186,605 shares. The stock had previously closed at $64.95.

Rocket Lab News Summary

Here are the key news stories impacting Rocket Lab this week:

  • Positive Sentiment: Rocket Lab won a $397 million U.S. Space Force contract to develop, launch, and operate Flatellite spacecraft for the Space-Based Airborne Moving Target Indicator program. The award expands Rocket Lab’s role in military space-based surveillance, includes an option for additional satellites, and is expected to use the company’s Neutron rocket. Rocket Lab Awarded $397 Million Contract
  • Positive Sentiment: The contract highlights Rocket Lab’s vertically integrated model—covering spacecraft, launch services, and mission operations—and could improve the company’s long-term revenue visibility and credibility with government and defense customers. Rocket Lab Shares Rise After Space Force Contract
  • Positive Sentiment: Several analysts remain bullish, with recently cited price targets ranging from $96 to $135 and a median target of $120. Commentators also favor Rocket Lab as a long-term innovation or space investment, supporting investor enthusiasm. Tesla vs. Rocket Lab
  • Neutral Sentiment: Investors are positioning ahead of second-quarter results. Expectations reportedly call for continued strong revenue growth, but the earnings release could increase volatility depending on guidance, Neutron development, and contract execution updates. Rocket Lab Earnings Preview
  • Neutral Sentiment: Analyst opinion is not unanimous. Rocket Lab retains a broadly favorable recommendation, but coverage describes disagreement over valuation and the company’s outlook after its recent rally. Analysts Conflicted on Rocket Lab
  • Negative Sentiment: Risk factors include Rocket Lab’s still-negative earnings, a high valuation, execution dependence on Neutron, and concerns that potential strategic expansion—including a reported Iridium acquisition—could require substantial financing or stock dilution. Recent insider activity has also been heavily weighted toward selling.

Wall Street Analysts Forecast Growth

Several analysts recently commented on RKLB shares. Citizens Jmp raised their price target on shares of Rocket Lab from $95.00 to $130.00 and gave the company a “market outperform” rating in a research report on Tuesday, June 30th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Rocket Lab in a research report on Friday, July 17th. Citigroup reissued a “market outperform” rating on shares of Rocket Lab in a research note on Tuesday, July 28th. KGI Securities upgraded Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 target price on the stock in a research report on Monday, July 27th. Finally, KeyCorp upgraded Rocket Lab from a “sector weight” rating to an “overweight” rating and set a $135.00 price target for the company in a research note on Monday, June 15th. Three investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $110.29.

Get Our Latest Research Report on RKLB

Rocket Lab Stock Up 0.7%

The business has a 50-day moving average price of $93.04 and a 200-day moving average price of $86.10. The stock has a market cap of $43.40 billion, a PE ratio of -233.58 and a beta of 2.60. The company has a current ratio of 4.47, a quick ratio of 4.02 and a debt-to-equity ratio of 0.02.

Rocket Lab (NASDAQ:RKLBGet Free Report) last issued its quarterly earnings results on Thursday, May 7th. The rocket manufacturer reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $200.35 million during the quarter, compared to analyst estimates of $189.65 million. Rocket Lab had a negative net margin of 26.87% and a negative return on equity of 11.72%. The firm’s revenue was up 63.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.12) EPS. As a group, analysts forecast that Rocket Lab Corporation will post -0.26 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Alexander R. Slusky sold 40,000 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $123.60, for a total transaction of $4,944,000.00. Following the completion of the sale, the director owned 334,675 shares of the company’s stock, valued at $41,365,830. The trade was a 10.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Marvin Bradford Clevenger sold 3,500 shares of the company’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $146.67, for a total transaction of $513,345.00. Following the transaction, the insider owned 473,975 shares of the company’s stock, valued at approximately $69,517,913.25. This trade represents a 0.73% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 3,849,294 shares of company stock valued at $362,816,208. 8.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Rocket Lab

A number of hedge funds have recently made changes to their positions in the company. Mcguire Capital Advisors Inc. purchased a new stake in shares of Rocket Lab during the fourth quarter worth approximately $27,000. Zions Bancorporation National Association UT purchased a new position in Rocket Lab in the 4th quarter valued at $28,000. EverSource Wealth Advisors LLC lifted its holdings in Rocket Lab by 109.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 796 shares of the rocket manufacturer’s stock valued at $28,000 after purchasing an additional 416 shares in the last quarter. Gordian Capital Singapore Pte Ltd acquired a new stake in Rocket Lab during the 4th quarter worth $29,000. Finally, Reflection Asset Management acquired a new stake in Rocket Lab during the 4th quarter worth $30,000. Institutional investors and hedge funds own 71.78% of the company’s stock.

About Rocket Lab

(Get Free Report)

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.

Recommended Stories

Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.